Items where the Publication is Pharmaceutical statistics
Number of items: 13.
B
  • Missing data: Discussion points from the PSI missing data expert group. (2009) Burzykowski, T; Carpenter, J; Coens, C; Evans, D; France, L; Kenward, M; Lane, P; Matcham, J; Morgan, D; Phillips, A; Roger, J; Sullivan, B; White, I; Yu, LM
  • Missing data: discussion points from the PSI missing data expert group. (2010) Burzykowski, Tomasz; Carpenter, James; Coens, Corneel; Evans, Daniel; France, Lesley; Kenward, Mike; Lane, Peter; Matcham, James; Morgan, David; Phillips, Alan; Roger, James; Sullivan, Brian; White, Ian; Yu, Ly-Mee; of the PSI Missing Data Expert Group
    • C
  • Handling Partially Observed Trial Data After Treatment Withdrawal: Introducing Retrieved Dropout Reference-Base Centred Multiple Imputation. (2024) Cro, Suzie; Roger, James H; Carpenter, James R
    • F
  • Subgroup analyses in cost-effectiveness analyses to support health technology assessments. (2014) Fletcher, Christine; Chuang-Stein, Christy; Paget, Marie-Ange; Reid, Carol; Hawkins, Neil
    • J
  • Bayesian Solutions for Assessing Differential Effects in Biomarker Positive and Negative Subgroups. (2024) Jackson, Dan; Zhang, Fanni; Burman, Carl-Fredrik; Sharples, Linda
    • L
  • Bias and precision of measures of survival gain from right-censored data. (2015) Lamb, Karen E; Williamson, Elizabeth J; Coory, Michael; Carlin, John B
    • N
  • Risk patterns in drug safety study using relative times by accelerated failure time models when proportional hazards assumption is questionable: an illustrative case study of cancer risk of patients on glucose-lowering therapies. (2015) Ng, Edmond S-W; Klungel, Olaf H; Groenwold, Rolf HH; van Staa, Tjeerd-Pieter
    • P
  • Estimands: discussion points from the PSI estimands and sensitivity expert group. (2016) Phillips, Alan; Abellan-Andres, Juan; Soren, Andersen; Bretz, Frank; Fletcher, Chrissie; France, Lesley; Garrett, Andrew; Harris, Raymond; Kjaer, Magnus; Keene, Oliver; Morgan, David; O'Kelly, Michael; Roger, James
  • Why a Bayesian approach to safety analysis in pharmacovigilance is important. (2011) Prieto-Merino, David; Quartey, George; Wang, Jixian; Kim, Joseph
    • Q
  • Opportunities for minimization of confounding in observational research. (2011) Quartey, George; Feudjo-Tepie, Maurille; Wang, Jixian; Kim, Joseph
    • R
  • A novel approach to estimation of the time to biomarker threshold: applications to HIV. (2016) Reddy, Tarylee; Molenberghs, Geert; Njagi, Edmund Njeru; Aerts, Marc
    • W
  • A win ratio approach to comparing continuous non-normal outcomes in clinical trials. (2016) Wang, Duolao; Pocock, Stuart
  • Standard and reference-based conditional mean imputation. (2022) Wolbers, Marcel; Noci, Alessandro; Delmar, Paul; Gower-Page, Craig; Yiu, Sean; Bartlett, Jonathan W